We are live on ! Find out more
UPC icon

Universe Pharmaceuticals Inc

1 hedge funds and large institutions have $1.09K invested in Universe Pharmaceuticals Inc in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% less ownership

Funds ownership: 0.67%0.15% (-0.52%)

67% less funds holding

Funds holding: 31 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less capital invested

Capital invested by funds: $344K → $1.09K (-$343K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.95K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1.09K +$2.95K +266 New
SM
2
Sabby Management
Florida
-$203K -8,334 Closed
AFM
3
Anson Funds Management
Texas
-$141K -5,760 Closed
Morgan Stanley
4
Morgan Stanley
New York
-$40 -2 Closed

UPC Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q1 2025, worth a combined $1.09K — down 100% from $344K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of UPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS Group, opening a new position worth an estimated $2.95K. The largest seller was Sabby Management, exiting entirely with an estimated $203K sold.

  • 1 institutional investor held Universe Pharmaceuticals Inc (UPC) as of Q1 2025, down from 3 in Q4 2024.
  • Funds reported $1.09K of Universe Pharmaceuticals Inc stock for Q1 2025, down 100% quarter-over-quarter.
  • 1 fund opened new Universe Pharmaceuticals Inc positions in Q1 2025 and 3 closed out, a net change of -2 holders.
  • The largest Universe Pharmaceuticals Inc buyer in Q1 2025 was UBS Group, an estimated $2.95K added.
  • The largest Universe Pharmaceuticals Inc seller in Q1 2025 was Sabby Management, an estimated $203K sold.

Based on aggregated 13F filings for Q1 2025.